Oxygenation Saturation Index Predicts Clinical Outcomes in ARDS.

Chest

Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN. Electronic address:

Published: December 2017

Background: Traditional measures of ARDS severity such as Pao/Fio may not reliably predict clinical outcomes. The oxygenation index (OI [Fio × mean airway pressure × 100)/Pao]) may more accurately reflect ARDS severity but requires arterial blood gas measurement. We hypothesized that the oxygenation saturation index (OSI [Fio × mean airway pressure × 100)/oxygen saturation by pulse oximetry (Spo)]) is a reliable noninvasive surrogate for the OI that is associated with hospital mortality and ventilator-free days (VFDs) in patients with ARDS.

Methods: Critically ill patients enrolled in a prospective cohort study were eligible if they developed ARDS (Berlin criteria) during the first 4 ICU days and had mean airway pressure, Spo/Fio, and Pao/Fio values recorded on the first day of ARDS (N = 329). The highest mean airway pressure and lowest Spo/Fio and Pao/Fio values were used to calculate OI and OSI. The association between OI or OSI and hospital mortality or VFD was analyzed by using logistic regression and linear regression, respectively. The area under the receiver-operating characteristic curve (AUC) for mortality was compared among OI, OSI, Spo/Fio, Pao/Fio, and Acute Physiology and Chronic Health Evaluation II scores.

Results: OI and OSI were strongly correlated (rho = 0.862; P < .001). OSI was independently associated with hospital mortality (OR per 5-point increase in OSI, 1.228 [95% CI, 1.056-1.429]; P = .008). OI and OSI were each associated with a reduction in VFD (OI, P = .023; OSI, P = .005). The AUC for mortality prediction was greatest for Acute Physiology and Chronic Health Evaluation II scores (AUC, 0.695; P < .005) and OSI (AUC, 0.602; P = .007). The AUC for OSI was substantially better in patients aged < 40 years (AUC, 0.779; P < .001).

Conclusions: In patients with ARDS, the OSI was correlated with the OI. The OSI on the day of ARDS diagnosis was significantly associated with increased mortality and fewer VFDs. The findings suggest that OSI is a reliable surrogate for OI that can noninvasively provide prognostic information and assessment of ARDS severity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812755PMC
http://dx.doi.org/10.1016/j.chest.2017.08.002DOI Listing

Publication Analysis

Top Keywords

osi
14
ards severity
12
hospital mortality
12
spo/fio pao/fio
12
oxygenation saturation
8
clinical outcomes
8
ards
8
[fio × airway
8
airway pressure ×
8
associated hospital
8

Similar Publications

Association of NOX5 Expression with Sperm Activity and Motility in Pathospermic Infertile Men.

J Reprod Infertil

January 2024

Department of Histology and Embryology, Istanbul Medeniyet University, School of Medicine, Istanbul, Turkey.

Background: The newest NOX isoform, NOX5, has been found in mammalian spermatozoa. Many physiological and pathological situations in spermatozoa are mediated by reactive oxygen species (ROS). NOX5 is the main source of ROS in spermatozoa.

View Article and Find Full Text PDF

A multi-modal computational fluid dynamics model of left atrial fibrillation haemodynamics validated with 4D flow MRI.

Biomech Model Mechanobiol

January 2025

Laboratoire d'Imagerie Biomédicale (LIB), Institut National de La Recherche Médicale (INSERM), Centre National de La Recherche Scientifique (CNRS), Sorbonne Université, Paris, France.

Atrial fibrillation (AF) is characterized by rapid and irregular contraction of the left atrium (LA). Impacting LA haemodynamics, this increases the risk of thrombi development and stroke. Flow conditions preceding stroke in these patients are not well defined, partly due the limited resolution of 4D flow magnetic resonance imaging (MRI).

View Article and Find Full Text PDF

In situ biosensing for cell viability and drug evaluation in 3D extracellular matrix cultures: Applications in cytoprotection of oxidative stress injury.

Talanta

January 2025

Department of Pharmaceutical Analysis, Higher Educational Key Laboratory for Nano Biomedical Technology of Fujian Province, Faculty of Pharmacy, Fujian Medical University, Fuzhou, 350122, China. Electronic address:

The rise of extracellular matrix (ECM)-supported three-dimensional (3D) cell culture systems which bridge the gap between in vitro culture and in vivo living tissue for pharmacological models has increased the need for simple and robust cell viability assays. This study presents the development of an effective biosensing assay for in situ monitoring of the catecholamine neurotransmitter exocytosis levels for cell viability assessment within complicated cell-encapsulated hydrogel milieu. Firstly, the biosensing assay demonstrated the distinction among four pheochromocytoma (PC12) cell lines with varying degrees of differentiation and the discrepancy in cellular neurosecretory capacity between two-dimensional (2D) monolayer and 3D agarose hydrogel culture conditions, accompanied by morphological distinctions.

View Article and Find Full Text PDF

Aspiration of cerumen plugs by nurses in a Primary Care Center: a pilot study.

Enferm Clin (Engl Ed)

January 2025

Enfermeras de Atención Primaria del Centro de Salud de Gros-Osakidetza, OSI Donostialdea, Avenida de navarra, 14 20013 San Sebastián, Guipúzcoa, Spain.

View Article and Find Full Text PDF

Background: To investigate the preventive efficacy of methylsulfonylmethane (MSM) on alveolar bone destruction in rats with periodontitis.

Methods: Twenty-four male Sprague-Dawley rats were randomly divided into three groups: control, experimental periodontitis (Ep), and Ep-MSM. Periodontitis was induced by placing 4.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!